-

$undefined

N/A

(N/A)

Achieve Life Sciences NasdaqCM:ACHV Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc., which is headquartered in Vancouver, Canada.

Location: 1040 West Georgia Street, Vancouver, BC, V6E 4H1, Canada | Website: https://www.achievelifesciences.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

110.9M

Cash

23.25M

Avg Qtr Burn

-8.893M

Short % of Float

8.97%

Insider Ownership

9.69%

Institutional Own.

41.59%

Qtr Updated

03/31/25